The measles immunization coverage for children aged 12-23 months in the UK is stable yet slightly declining, with forecasts showing a consistent 89% coverage in 2024 and 2025, decreasing to 88% from 2026 through 2028. As of 2023, the coverage was at 89%, indicating no significant change from 2023 to 2024. This stability implies the UK has maintained relatively high immunization levels, but the slight drop anticipated from 2026 calls for attention. The compound annual growth rate (CAGR) from 2024 to 2028 is negligible, aligning with minimal variation year-on-year.
Future trends to watch for:
- Public health campaigns targeting immunization awareness and encouragement.
- The potential impact of demographic shifts or changes in healthcare policies.
- Monitoring of anti-vaccine sentiment which could affect future rates.
